TimeEvent
08:10 - 08:15

Official Opening

Freddy Penninckx (President), Ronan O'Connell (Secretary), Emmanuel Tiret (Program Committee Chairman)
08:15 - 10:30

Video Surgery

Chairs: José M Enriquez-Navascues (Spain), Paul Antoine Lehur (France)

  • ETAR (Endoscopic Trans Anal Resection) technique - Alex Kartheuser (Belgium)
  • Natural orifice proctectomy with total mesorectal excision using transanal port and laparoscopic assistance - Francis Michot (France)
  • Robotic TME - Daniel Langer (Czech Republic)
  • Rectovaginal fistula: martius flap revisited - Katalin Kalmar, Shahram Ghotb Sajjadi, Ors Peter Horvarth (Hungary)
Discussion
  • Transperineal rectocele repair with porcine dermal collagen implant - Giovanni Milito (Italy)
  • Rectovaginal fistula after ileoanal pouch in UC - Julio Leite (Portugal)
  • Laparoscopic ventral recto-colpo-pexy for rectal prolapse - Marcos Rodrigues Martin (Spain)
  • One-instrument laparoscopic colon resection with end-to-end bonding anastomosis - Sergii Podpriatov (Ukraine)
Discussion

Clinical Trials Update

Chairs: Søren Laurberg (Denmark), James Hill (UK)

Guest speaker: James Hill (UK) - ColoRectal Endoscopic Stenting Trial (CReST)

A session featuring the best selection of submitted trials abstracts

10:30 - 11:10

Coffee/Exhibition/Posters

11:10 - 11:40

Keynote Lecture: Antiplatelet and anticoagulation agents and colorectal surgery

Speaker: Jørn Dalsgaard Nielsen (Denmark)

Chair: Ronan O'Connell (Ireland)

11:40 - 13:00

The Six Best and Visiting Fellow Free Papers

Chairs: Freddy Penninckx (Belgium) - ESCP President, Zoran Krivokapic (Serbia) - ESCP President Elect

  • Japanese Visiting Fellow free paper
  • ASCRS Visiting Fellow free paper

The Six Best ESCP free papers:

  • B1 Intraoperative complications of laparoscopic colorectal resections: Did we get better? - Patryk Kambakamba (Switzerland)
  • B2 Influence of two policies of closure of the laparotomy wound upon the incidence of incisional surgical site infection in colorectal cancer surgery. Results of a randomised trial - Eloy Espin (Spain)
  • B3 Electroacupuncture for postoperative ileus after laparoscopic colorectal surgery: a randomized sham-controlled study - Simon Ng (Hong Kong)
  • B4 Does overt rectal prolapse always need a surgical treatment? - Laurent Siproudhis (France)
  • B5 Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial - Wilhelm Graf (Sweden)
  • B6 Does R1 resection compromise local control after conservative surgery for low rectal cancer? - Christophe Laurent (France)
13:00 - 14:00 Lunch/Exhibition/Posters
view poster titles and presenters
14:00 - 15:00

Symposium: Neoadjuvant therapy for rectal cancer

Chairs: Mariana Behro (USA), Werner Hohenberger (Germany)

  • Tumour response assessment after chemoradiation - Rodrigo Perez (Brazil)
  • Which regimen gives best results? - Torbjörn Holm (Sweden)
  • Long term outcome of the Dutch and CRO7 trials - Cornelis van de Velde (The Netherlands)
Discussion
15:00 - 15:30

Keynote Lecture: Colorectal GIST

Speaker: Bruno Cola (Italy)

Chair: Mirko Omejc (Slovenia)

15:30 - 15:35

Award: Best of the Six Best Papers

This award is supported by the British Journal of Surgery

15:35 - 16.00 Coffee/Exhibition/Posters
16.00 - 17:30

Free Papers (main auditorium)

Chairs: Peter Dawson (UK), Marek Szczepkowski (Poland)

  • F1 Long-term results intraoperative pelvic hyperthermic chemotherapy for the locally advanced rectal carcinoma - Mikhail Alekseev (Russia)
  • F2 Defunctioning stoma and leak rate after total mesorectal excision with colo-anal anastomosis in the context of a national project - Freddy Penninckx (Belgium)
  • F3 How do postoperative mortality ‘outlier’ institutions for colorectal cancer surgery perform on other measures of quality? - Alex M. Almoudaris (UK)
  • F4 Higher frequency of anastomotic leakage in stapled compared to hand-sewn ileocolic anastomoses in a large population-based study - Pia Jestin (Sweden)
  • F5 Risk factors, prevalence and incidence of colorectal peritoneal carcinomatosis - a population-based study - Josefin Segelman (Sweden)
  • F6 Specific pattern of Volatile Organic Compounds (VOCs) identifies colorectal cancer patients. A new potential screening test - Donato Francesco Altomare (Italy)
  • F7 What is a safe distal resection margin in rectal cancer? - Tor E. Bernstein (Norway)
  • F8 Macroscopic and Morphometric Quality Assessment for Colonic Cancer: Comparison between Open and Laparoscopic Approach - Nikolaos Gouvas (Greece)
  • F9 CEA and MUC2 mRNA in lymph nodes are predictors of outcome in colorectal cancer - Gudrun Lindmark (Sweden)

Free Papers (parallel auditorium)

Chairs: David Waldron (Ireland), Milon Breberina (Serbia)

  • F10 Accuracy of Preoperative Magnetic Resonance Imaging in Prediction of Pathological Stage in Rectal Cancer: node-for-node matched histologic validation of MRI imaging features - Jun Seok Park (Republic of Korea)
  • F11 Angiogenic response to surgery in patients after curative colon cancer resection and its correlation with oncological results on long term follow up - Marta Pascual (Spain)
  • F12 Characterisation of endoluminal tumour deposits (ETDs) may expand rectal conserving alternatives to empirical radical surgery in rectal cancer undergoing neoadjuvant chemoradiotherapy - Fraser Smith (Ireland)
  • F13 The treatment of rectal prolapse in 2011; an international survey - Henk A. Formijne Jonkers (The Netherlands)
  • F14 Monitoring of internal anal sphincter innervation in patients undergoing total mesorectal excision and early functional outcome - Daniel W Kauff (Germany)
  • F15 Sacral Nerve Stimulation reduces Rectal Barrier Permeability in a Preclinical Porcine Model - Claire Blanchard (France)
  • F16 Randomized Controlled Trial of Alpha Blocker for Prevention of Acute Voiding Dysfunction After Rectal Cancer Surgery - Sung-Bum Kang (Republic of Korea)
  • F17 Autologous Cultured Adipose-derived Stem Cell for the Treatment of Crohn’s Fistula - Chang Sik Yu (Republic of Korea)
  • F18 Comparison between patients with perforating and not-perforating Crohn’s disease of the terminal ileum in a surgical population - Igors Iesalnieks (Germany)
Evening  Welcome Reception and Exhibition
ESCP Affiliates